Regeneron Overlap Studies All Moving Average

<div class='circular--portrait' style='background:#800000;color: #F8F8FF;font-size:4em;padding-top: 25px;;'>RP</div>
REGN -- USA Stock  

Fiscal Quarter End: 30th of June 2020  

Regeneron Pharmaceuticals overlap-studies tool provides you with the Overlap Studies execution environment for running All Moving Average study against Regeneron Pharmaceuticals. Regeneron Pharmaceuticals overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify Time Period and MA Type to execute this module.
Symbol
Refresh

The output start index for this execution was nine with a total number of output elements of fifty-two. The Moving Average is predictive technique used to analyze Regeneron Pharmaceuticals price data points by creating a series of averages of different subsets of Regeneron Pharmaceuticals entire price series. View also all equity analysis or get more info about all moving average overlap studies indicator.

Additional Technical Research

About Regeneron Pharmaceuticals Predictive Technical Analysis

The Macroaxis Predictive Technical Analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Regeneron Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Regeneron Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Regeneron Pharmaceuticals stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Regeneron Pharmaceuticals's daily price indicators and compare them against related drivers such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Regeneron Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Regeneron Pharmaceuticals, we also check how macroeconomic factors affect Regeneron Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Earnings
Estimates (1)
LowProjected EPSHigh
23.8423.8423.84
Details
Hype
Prediction
LowEstimated ValueHigh
490.69551.35555.35
Details
Intrinsic
Valuation
LowReal ValueHigh
498.16502.16599.73
Details
Naive
Forecast
LowNext ValueHigh
560.02564.01568.01
Details
Analysts
Consensus (21)
LowTarget PriceHigh
400.00540.89657.00
Details

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Current Thematic Trending

Purchased over 90 shares
Active few hours ago
Purchased over 70 shares
Active few hours ago
Purchased over 90 shares
Active few hours ago
Purchased one share
Active few hours ago
Purchased over 90 shares
Active few hours ago
Purchased over 90 shares
Active few hours ago
Additionally, take a look at Your Equity Center. Please also try Bollinger Bands module to use bollinger bands indicator to analyze target price for a given investing horizon.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page